KAP President Invites Trudeau To Visit Rural Western Canada

Oct 23, 2019

With the federal election now in the books, Keystone Agricultural Producers (KAP) President Bill Campbell is hoping that more attention will be paid to agriculture.

"I have not heard the word 'agriculture' very much," he commented. "We only need to realize that some of the leaders did not visit some Western Canadian ridings. They did not visit rural ridings and get outside of the major cities, so to say that a minority government will be able to achieve results for agriculture, I'm still in a wait and see mode."

Campbell is inviting Prime Minister Justin Trudeau and his ag minister to visit Manitoba to see first hand some of the challenges that farmers are facing, especially with the wet harvest conditions.

"I would like to send out a personal invitation to the Prime Minister and Minister of Agriculture, in spite of their busyness before the election, and we understand that, to come and visit Western Manitoba and rural Manitoba and rural Western Canada to actually feel and see some of the impacts that are being felt out here by producers and citizens of this country.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.